Skip to content
lifestyle.duovoltart.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
XellSmart Biopharmaceutical Co., Ltd.
New Progress — XellSmart Unveiled Phase I Results of Off-the-Shelf Parkinson’s Disease Cell Therapy at MDS & Completed Blinded Phase II Enrollment
October 18, 2026
FDA Grants Fast Track Designation to Xellsmart Off-The-Shelf Cell Therapy for Parkinson’s Disease
August 4, 2026